Although various protein–protein interactions with FUS have been identified through proteomic analysis (24), our data suggest that targeting the FUS RGG2 domain represents a potential means to prevent the toxic effect of ALS-FUS mutants. Here, FUS is linked to amyotrophic lateral sclerosis.